NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population
Xiaoying Chen(Centre National de la Recherche Scientifique), Shiwei Duan(Communication University of Zhejiang), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Yang(Ningbo University), Guili Liu(Ningbo University), Cong Li(The Affiliated Yongchuan Hospital of Chongqing Medical University), Bin Li(Meizhou City People's Hospital), Qi Xu(Zhejiang Cancer Hospital), Yan Xu(Ningbo University), Jing Liu(Fujian Medical University), Yingmin Chen(Shanghai Jiao Tong University)
Cited by 30
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
Circles reshaping the RNA world: from waste to treasure
|Molecular Cancer|2017|413